PSA Kinetics and PSA Bounce Following Permanent Seed Prostate Brachytherapy

International Journal of Radiation Oncology Biology Physics

Volumn 69, Issue 2, 2007, Pages 426-433

  Crook, Juanita ^a   Gillan, Caitlin ^a   Yeung, Ivan ^a   Austen, Lynette ^a   McLean, Michael ^a   Lockwood, Gina ^b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Biochemical failure; Prostate brachytherapy; Prostate specific antigen (PSA) bounce

Indexed keywords

DOSIMETRY; FAILURE ANALYSIS; RADIOTHERAPY; RISK ANALYSIS; ULTRASONICS;

BIOCHEMICAL FAILURE; FLUOROSCOPY; PROSTATE BRACHYTHERAPY; PROSTATE SPECIFIC ANTIGENS (PSA);

ANTIGENS;

IODINE 125; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BRACHYTHERAPY; CANCER STAGING; CHOLANGIOGRAPHY; CONTROLLED STUDY; DOSIMETRY; GLEASON SCORE; HORMONAL THERAPY; HUMAN; KINETICS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE; SEXUAL FUNCTION; ULTRASOUND;

AGE FACTORS; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TIME FACTORS;

EID: 34548497179     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.03.031     Document Type: Article

References (26)

1. Cherullo E.E., Ponsky L.E., Goyal K.K., et al. Variable definitions influence the reporting of biochemical failure rates. Prostate Cancer Prostatic Dis 5 (2002) 54-58
2. Critz F.A. A standard definition of disease freedom is needed for prostate cancer: Undetectable prostate specific antigen compared with the American Society of Therapeutic Radiology and Oncology consensus definition. J Urol 167 (2002) 1310-1313
3. Horwitz E.M., Uzzo R.G., Hanlon A.L., et al. Modifying the American Society for Therapeutic Radiology and Oncology definition of biochemical failure to minimize the influence of backdating in patients with prostate cancer treated with 3-dimensional conformal radiation therapy alone. J Urol 169 (2003) 2153-2157 discussion, 2157-2159
4. Horwitz E.M., Levy L.B., Thames H.D., et al. Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: A multiinstitutional pooled analysis. Cancer 107 (2006) 1496-1502
5. Kuban D.A., Thames H.D., and Levy L.B. PSA after radiation for prostate cancer. Oncology (Huntingt) 18 (2004) 595-604 discussion, 605, 609
6. Pickles T. Prostate-specific antigen (PSA) bounce and other fluctuations: Which biochemical relapse definition is least prone to PSA false calls? An analysis of 2030 men treated for prostate cancer with external beam or brachytherapy with or without adjuvant androgen deprivation therapy. Int J Radiat Oncol Biol Phys 64 (2006) 1355-1359
7. Thames H., Kuban D., Levy L., et al. Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995. Int J Radiat Oncol Biol Phys 57 (2003) 929-943
8. Zietman A.L., Christodouleas J.P., and Shipley W.U. PSA bounces after neoadjuvant androgen deprivation and external beam radiation: Impact on definitions of failure. Int J Radiat Oncol Biol Phys 62 (2005) 714-718
9. Consensus statement: Guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiat Oncol Biol Phys 37 (1997) 1035-1041
10. Roach III M., Hanks G., Thames Jr. H., et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 65 (2006) 965-974
11. Cavanagh W., Blasko J.C., Grimm P.D., et al. Transient elevation of serum prostate-specific antigen following (125)I/(103)Pd brachytherapy for localized prostate cancer. Semin Urol Oncol 18 (2000) 160-165
12. Ciezki J.P., Reddy C.A., Garcia J., et al. PSA kinetics after prostate brachytherapy: PSA bounce phenomenon and its implications for PSA doubling time. Int J Radiat Oncol Biol Phys 64 (2006) 512-517
13. Critz F.A., Williams W.H., Benton J.B., et al. Prostate specific antigen bounce after radioactive seed implantation followed by external beam radiation for prostate cancer. J Urol 163 (2000) 1085-1089
14. Critz F.A., Williams W.H., Levinson A.K., et al. Prostate specific antigen bounce after simultaneous irradiation for prostate cancer: The relationship to patient age. J Urol 170 (2003) 1864-1867
15. Das P., Chen M.H., Valentine K., et al. Using the magnitude of PSA bounce after MRI-guided prostate brachytherapy to distinguish recurrence, benign precipitating factors, and idiopathic bounce. Int J Radiat Oncol Biol Phys 54 (2002) 698-702
16. Merrick G.S., Butler W.M., Wallner K.E., et al. Prostate-specific antigen spikes after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 54 (2002) 450-456
17. Merrick G.S., Butler W.M., Wallner K.E., et al. Prostate-specific antigen (PSA) velocity and benign prostate hypertrophy predict for PSA spikes following prostate brachytherapy. Brachytherapy 2 (2003) 181-188
18. Morita M., Lederer J.L., Fukagai T., et al. [PSA bounce phenomenon after transperineal interstitial permanent prostate brachytherapy for localized prostate cancer]. Nippon Hinyokika Gakkai Zasshi 95 (2004) 609-615
19. Patel C., Elshaikh M.A., Angermeier K., et al. PSA bounce predicts early success in patients with permanent iodine-125 prostate implant. Urology 63 (2004) 110-113
20. Reed D., Wallner K., Merrick G., et al. Clinical correlates to PSA spikes and positive repeat biopsies after prostate brachytherapy. Urology 62 (2003) 683-688
21. Stock R.G., Stone N.N., and Cesaretti J.A. Prostate-specific antigen bounce after prostate seed implantation for localized prostate cancer: Descriptions and implications. Int J Radiat Oncol Biol Phys 56 (2003) 448-453
22. Toledano A., Chauveinc L., Flam T., et al. PSA bounce after permanent implant prostate brachytherapy may mimic a biochemical failure: A study of 295 patients with a minimum 3-year followup. Brachytherapy 5 (2006) 122-126
23. Taussky D., Austen L., Toi A., et al. Sequential evaluation of prostate edema after permanent seed prostate brachytherapy using CT-MRI fusion. Int J Radiat Oncol Biol Phys 62 (2005) 974-980
24. Feigenberg S.J., Hanlon A.L., Horwitz E.M., et al. A prostate specific antigen (PSA) bounce greater than 1.4 ng/mL is clinically significant after external beam radiotherapy for prostate cancer. Am J Clin Oncol 29 (2006) 458-462
25. Rosser C.J., Kamat A.M., Wang X., et al. Is patient age a factor in the occurrence of prostate-specific antigen bounce phenomenon after external beam radiotherapy for prostate cancer?. Urology 66 (2005) 327-331
26. Crook J., Malone S., Perry G., et al. Postradiotherapy prostate biopsies: What do they really mean? Results for 498 patients. Int J Radiat Oncol Biol Phys 48 (2000) 355-367